HEMODYNAMIC STUDIES ON MEXILETINE, A NEW ANTIARRHYTHMIC AGENT

被引：0
|
作者：
POZENEL, H [1 ]
机构：
[1] SPECIAL TREATMENT CTR CARDIOVASC DIS,AGR WORKERS SOCIAL SECURITY SCHEME,A-4540 BAD HALL,AUSTRIA
来源：
POSTGRADUATE MEDICAL JOURNAL | 1977年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [1] ANTIARRHYTHMIC AND HEMODYNAMIC EFFECTS OF MEXILETINE
    KUHN, P
    KROISS, A
    KLICPERA, M
    ZILCHER, H
    KAINDL, F
    POSTGRADUATE MEDICAL JOURNAL, 1977, 53 : 81 - 83
  • [2] MEXILETINE - A NEW TYPE-I ANTIARRHYTHMIC AGENT
    SCHRADER, BJ
    BAUMAN, JL
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (04): : 255 - 260
  • [3] CLINICAL AND HEMODYNAMIC INVESTIGATION WITH MEXILETINE (KO 1173) - NEW ANTIARRHYTHMIC DRUG
    POZENEL, H
    HERZ KREISLAUF, 1977, 9 (03): : 148 - 152
  • [4] MEXILETINE, A NEW ANTIARRHYTHMIC AGENT, FOR TREATMENT OF PREMATURE VENTRICULAR COMPLEXES
    MEHTA, J
    CONTI, CR
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (02): : 455 - 460
  • [5] HEMODYNAMIC-EFFECTS OF A NEW ANTIARRHYTHMIC AGENT - CIBENZOLINE
    RIGAUD, M
    JOURET, G
    CANAL, M
    BARDET, J
    FLOUVAT, B
    BOURDARIAS, JP
    JOURNAL DE PHARMACOLOGIE, 1985, 16 (03) : 247 - 257
  • [6] ELECTROPHYSIOLOGIC AND HEMODYNAMIC PROPERTIES OF NEW ANTIARRHYTHMIC AGENT, DIPHENIDOL
    HAYAKAWA, H
    MANDEL, W
    VYDEN, J
    PARMLEY, W
    CORDAY, E
    CIRCULATION, 1971, 44 (04) : 175 - &
  • [7] ANTIARRHYTHMIC AND HEMODYNAMIC EFFECTS OF MEXILETINE AFTER ORAL-ADMINISTRATION TO MEN
    KLICPERA, M
    KROISS, A
    ZILCHER, H
    KUHN, P
    HERZ KREISLAUF, 1977, 9 (03): : 153 - 160
  • [8] NEW ANTIARRHYTHMIC AGENTS - AMIODARONE, MEXILETINE, TOCAINIDE
    MANDEL, WJ
    KARAGUEUZIAN, HS
    PETER, T
    WESTERN JOURNAL OF MEDICINE, 1985, 143 (01): : 96 - 97
  • [9] HEMODYNAMIC-EFFECTS OF PIRMENOL, A NEW ANTIARRHYTHMIC AGENT, ASSESSED NONINVASIVELY
    TOIVONEN, LK
    NIEMINEN, MS
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1986, 10 (02) : 111 - 118
  • [10] Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine
    Labbé, L
    Abolfathi, Z
    Robitaille, NM
    St-Maurice, F
    Gilbert, M
    Turgeon, J
    THERAPEUTIC DRUG MONITORING, 1999, 21 (02) : 191 - 199
12345